ORPN - Bioblast Pharma Ltd.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
2.18
-0.11 (-4.80%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close2.29
Open2.22
Bid1.97 x 4000
Ask2.74 x 1800
Day's Range2.12 - 2.28
52 Week Range1.49 - 5.99
Volume73,959
Avg. Volume135,087
Market Cap7.286M
Beta0.86
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Benzinga16 days ago

    Benzinga Pro's 6 Stocks To Watch Today

    Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! athenahealth, Inc (NASDAQ: ATHN ) stock was trading ...

  • What Kind Of Risk Should You Expect For Bioblast Pharma Ltd (NASDAQ:ORPN)?
    Simply Wall St.last month

    What Kind Of Risk Should You Expect For Bioblast Pharma Ltd (NASDAQ:ORPN)?

    If you are looking to invest in Bioblast Pharma Ltd’s (NASDAQ:ORPN), or currently own the stock, then you need to understand its beta in order to understand how it canRead More...

  • Should You Be Concerned About Bioblast Pharma Ltd’s (NASDAQ:ORPN) Investors?
    Simply Wall St.3 months ago

    Should You Be Concerned About Bioblast Pharma Ltd’s (NASDAQ:ORPN) Investors?

    I am going to take a deep dive into Bioblast Pharma Ltd’s (NASDAQ:ORPN) most recent ownership structure, not a frequent subject of discussion among individual investors. A company’s ownership structureRead More...

  • Benzinga4 months ago

    ICYMI: Shutterfly Downgrade, BioBlast Price Action, Blockchain ETFs

    In case you missed it, here are some of Benzinga's top stories from Wednesday, Jan. 17, 2018. Blockchain ETFs’ Inaugural Trading Session Wayne Duggan breaks down the arrival of new ETFs - Reality Shares ...

  • Should You Invest In The Healthcare Stock Bioblast Pharma Ltd (ORPN)?
    Simply Wall St.7 months ago

    Should You Invest In The Healthcare Stock Bioblast Pharma Ltd (ORPN)?

    Bioblast Pharma Ltd (NASDAQ:ORPN), a USD$7.59M small-cap, operates in the healthcare industry, which continues to be affected by the sustained economic uncertainty and structural trends, such as an aging population,Read More...

  • Associated Press7 months ago

    Bio Blast reports 3Q loss

    The Tel Aviv, Israel-based company said it had a loss of 32 cents per share. The company's shares closed at $2.27. A year ago, they were trading at $7.15. _____ This story was generated by Automated Insights ...

  • Associated Press10 months ago

    Bio Blast reports 2Q loss

    On a per-share basis, the Tel Aviv, Israel-based company said it had a loss of 10 cents. In the final minutes of trading on Friday, the company's shares hit 64 cents. A year ago, they were trading at $1.58. ...

  • Associated Presslast year

    Bio Blast reports 1Q loss

    The Tel Aviv, Israel-based company said it had a loss of 16 cents per share. In the final minutes of trading on Friday, the company's shares hit 45 cents. A year ago, they were trading at $2.08. _____ ...